Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee (MedCAC)-October 22, 2007, 48652-48654 [E7-16825]
Download as PDF
<![CDATA[
48652
Federal Register / Vol. 72, No. 164 / Friday, August 24, 2007 / Notices
• Action Subcommittee (Chairperson,
Julie Nelson, J.D.) charged with
identifying issues other than on-call
issues.
• Framework Subcommittee
(Chairperson, Charlotte Yeh, M.D.)
charged with clarifying the historical
context and conceptual basis for the
TAG’s recommendations and
developing a document for review and
approval by the TAG.
II. Meeting Format, Agenda, and
Presentation Topics
III. Registration Instructions
A. Meeting Format
The initial portion of the meeting,
which will convene at 9 a.m. on
September 17, will involve opening
remarks and will be followed by a
limited period of public testimony on
issues related to EMTALA and its
implementation. TAG members will
have the opportunity to ask questions,
prioritize the topics presented, and to
conduct other necessary business. At
the conclusion of each day’s meeting, to
the extent that time is available and at
the discretion of the Chairperson, the
public will be permitted a reasonable
time to comment on issues being
considered by the TAG.
B. Tentative Meeting Agenda
The tentative agenda for the EMTALA
TAG meetings is as follows:
Day 1
Convenes at 9 a.m.
• Welcome, Call to Order, and
Opening Remarks
• Administrative and Housekeeping
Issues
• Public Testimony on Issues Related
to EMTALA and Its Implementation
• Subcommitte Reports
• Public Comment.
yshivers on PROD1PC66 with NOTICES
Day 2
Convenes at 9 a.m.
• Subcommittee Reports (cont.)
• Public Comment.
C. Public Presentations
Only individuals who register and
submit written testimony as specified in
the SECURITY INFORMATION section of this
notice will be considered registered
presenters. The time allotted for each
presentation will be approximately 5
minutes and will be based on the
number of registered presenters.
Presenters will speak in their assigned
order. If registered presenters are not
given an opportunity to speak because
of time restrictions, we will accept and
present their written testimony to the
TAG members. Comments from other
participants (individuals who are not
registered presenters) may be heard after
VerDate Aug<31>2005
14:35 Aug 23, 2007
Jkt 211001
the scheduled testimonies, if time
permits.
If there are individuals who cannot
attend the meeting but wish to submit
comments/statements regarding issues
related to the EMTALA TAG, we will
accept and present their written
comments/statements at the meeting if
their comments/statements are received
by postal mail or email at the address
listed in the ADDRESSES section of this
notice by September 3, 2007.
The Center for Medicare Management
of CMS is coordinating meeting
registration. While there is no
registration fee, all individuals must
register to attend due to limited seating.
As specified in the DATES section of this
notice, individuals who wish to attend
the meeting but do not plan to present
testimony must register by September
10, 2007. Individuals who would like
both to attend and to present testimony
on issues relating to the EMTALA TAG
must register by August 27, 2007 and
must state specifically in their
registration request that they wish to
present testimony for EMTALA TAG
consideration. A copy of the presenter’s
written testimony must be received by
CMS at the address specified in the
ADDRESSES section of this notice by
September 3, 2007.
You may register by sending an e-mail
to Marianne Myers at
Marianne.Myers@cms.hhs.gov, by fax to
the attention of Marianne Myers at (410)
786–0681, or by telephone at (410) 786–
5962. All registration requests must
include your name, name of the
organization (if applicable), address,
telephone and fax numbers, e-mail
address (if available). Individuals will
receive a registration confirmation with
instructions for your arrival at the
Wilbur J. Cohen Building. If seating
capacity has been reached, registrants
will be notified that the meeting has
reached capacity. All registrants are
asked to arrive at the Wilbur J. Cohen
Building no later than 20 minutes before
the scheduled starting time of each
meeting session they wish to attend.
IV. Security Information
Since this meeting will be held in a
Federal government building, Federal
security measures are applicable. As
noted above, in planning your arrival
time, we recommend allowing
additional time to clear security. In
order to gain access to the building,
participants must bring a governmentissued photo identification such as a
driver’s license or a passport and a copy
of your registration information for the
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
meeting. Access may be denied to
persons without proper identification.
All persons entering the building
must pass through a metal detector. In
addition, all items brought to CMS,
whether personal or for the purpose of
demonstration or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
demonstration or to support a
presentation.
V. Selection of New EMTALA TAG
Member
In the March 15, 2005 Federal
Register (70 FR 12691), we announced
the EMTALA TAG membership. One of
those original members, a hospital
representative, is unable to complete his
term of service. In selecting a
replacement, the TAG must maintain
the member composition described in
section 945(b) of the MMA. We note that
section 945(b)(1) of the MMA specifies
that: ‘‘4 [members of the TAG] shall be
representatives of hospitals.’’ For this
reason and to ensure that the concerns
of hospitals are appropriately
considered during TAG deliberations,
another hospital representative has been
selected to serve as a member of the
TAG. The new member is Rachel Seifert
of Community Health Systems in
Franklin, Tennessee.
Authority: Section 945 of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA).
Dated: August 16, 2007.
Herb Kuhn,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. E7–16583 Filed 8–23–07; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3184–N]
Medicare Program; Meeting of the
Medicare Evidence Development and
Coverage Advisory Committee
(MedCAC)—October 22, 2007
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces a
public meeting of the Medicare
Evidence Development & Coverage
Advisory Committee (MedCAC)
E:\FR\FM\24AUN1.SGM
24AUN1
Federal Register / Vol. 72, No. 164 / Friday, August 24, 2007 / Notices
(‘‘Committee’’) entitled CMS
Evidentiary Priorities for Medicare. The
Committee generally provides advice
and recommendations about whether
scientific evidence is adequate to
determine if certain medical items and
services are reasonable and necessary
under the Medicare statute.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)).
DATES: The public meeting will be held
on Monday, October 22, 2007 from 7:30
a.m. until 4:30 p.m., d.s.t.
Deadline for Presentations and
Written Comments: Send written
comments and presentations to the
address specified in the ADDRESSES
section by 5 p.m., d.s.t. on September
17, 2007.
Deadline for Meeting Registration: For
security reasons, individuals wishing to
attend this meeting must register by 5
p.m. d.s.t. on October 15, 2007.
Deadline for Submitting Request for
Special Accommodations: Persons
attending the meeting who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to notify the Executive Secretary
as specified in the FOR FURTHER
INFORMATION CONTACT section of this
notice.
Meeting Location: The
meeting will be held in the main
auditorium of the Centers for Medicare
& Medicaid Services, 7500 Security
Blvd., Baltimore, MD 21244.
Registration: Register by contacting
Maria Ellis 410–786–0309, or
Maria.Ellis@cms.hhs.gov; Centers for
Medicare & Medicaid Services, OCSQ–
Coverage and Analysis Group,C1–09–
06, 7500 Security Blvd., Baltimore, MD
21244.
Presentation and Comment
Submission: Submit presentations and
comments to Michelle Atkinson, at
MedCACpresentations@cms.hhs.gov.
Web Site: You may access up-to-date
information on this meeting at https://
www.cms.hhs.gov/FACA/
02_aspTopOfPage.
Submission of Presentations and
Comments: Interested persons may
present data, information, or views
orally or in writing on issues pending
before the Committee. Please submit
written comments and presentations to
the Executive Secretary at the address
specified in the ADDRESSES section of
this notice. Presentations once
submitted are final. No further changes
to the presentation will be accepted
after submission.
FOR FURTHER INFORMATION CONTACT:
Michelle Atkinson, Executive Secretary
yshivers on PROD1PC66 with NOTICES
ADDRESSES:
VerDate Aug<31>2005
14:35 Aug 23, 2007
Jkt 211001
for MedCAC, Centers for Medicare &
Medicaid Services, OCSQ–Coverage and
Analysis Group, C1–09–06, 7500
Security Blvd., Baltimore, MD 21244.
410–786–2881;
Michelle.Atkinson@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Meeting Topic
On December 14, 1998, we published
a notice in the Federal Register (63 FR
68780) to describe the Medicare
Coverage Advisory Committee (MCAC),
which provides advice and
recommendations to CMS about clinical
issues. The MCAC was subsequently
rechartered as the Medicare Evidence
Development and Coverage Advisory
Committee (MedCAC).
This notice announces the October 22,
2007 public meeting of the Committee.
This meeting is to assist CMS in
developing priorities for evidence
development for issues of major
importance to the Medicare program
and the Medicare population to provide
a framework for the scientific
community advancement of research
projects that concern Medicare
beneficiaries. Certain disease processes
account for a large percentage of
services provided to our beneficiaries
and specific treatments and healthcare
delivery processes have a great impact
on beneficiary outcomes. The end
product of the MedCAC is a priority list
of research topics with the most
potential impact on Medicare and
Medicare beneficiaries to contribute to
the body of medical evidence specific to
the Medicare populations. Background
information about this topic, including
panel materials, is available at https://
www.cms.gov/coverage.
II. Meeting Procedures
This meeting is open to the public.
The Committee will hear oral
presentations from the public for
approximately 30 minutes. The
Committee may limit the number and
duration of oral presentations to the
time available. If you wish to make
formal presentations, you must do the
following:
• Notify the Executive Secretary as
specified in FOR FURTHER INFORMATION
CONTACT section of the notice.
• Submit the following to the address
specified in the ADDRESSES section of
this notice by the date specified in the
DATES section of this notice:
• A brief statement of the general
nature of the evidence or arguments you
wish to present.
• The names and addresses of
proposed participants.
• A written copy of your
presentation. Your presentation should
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
48653
consider the questions we have posed to
the Committee and focus on the issues
specific to the topic. The questions will
be available on the following Web site:
https://www.cms.hhs.gov/FACA/
02_aspTopOfPage.
We require that you declare at the
meeting whether you have any financial
involvement with manufacturers of any
items or services being discussed (or
with their competitors).
After the public and CMS
presentations, the Committee will
deliberate openly on the topic.
Interested persons may observe the
deliberations, but the Committee will
not hear further comments during this
time except at the request of the
chairperson. The Committee will also
allow a 15 minute unscheduled open
public session for any attendee to
address issues specific to the topic. At
the conclusion of the day, the members
will vote and the Committee will make
its recommendation.
III. Registration Instructions
The Coverage and Analysis Group is
coordinating meeting registration. While
there is no registration fee, individuals
must register to attend. Register by
contacting Maria Ellis as specified in the
ADDRESSES section of this notice by the
date as specified in the DATES section of
this notice. Please provide your name
(as it appears on your governmentissued identification), address,
organization, telephone, and fax
numbers, and e-mail address.
You will receive a registration
confirmation with instructions in
preparation for your arrival at the CMS
complex. You will be notified if the
seating capacity has been reached.
This meeting is located on Federal
property; therefore, for security reasons,
any individuals wishing to attend this
meeting must register by the date
specified in the DATES section of this
notice.
IV. Security, Building, and Parking
Guidelines
This meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security.
Security measures include the
following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Interior and exterior inspection of
vehicles (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
E:\FR\FM\24AUN1.SGM
24AUN1
48654
Federal Register / Vol. 72, No. 164 / Friday, August 24, 2007 / Notices
instructions will be issued after the
vehicle inspection.
• Passing through a metal detector
and inspection of items brought into the
building. We note that all items brought
to CMS, whether personal or for the
purpose of demonstration or to support
a demonstration, are subject to
inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 30 to 45 minutes prior
to the convening of the meeting.
All visitors must be escorted in areas
other than the lower and first floor
levels in the Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance
Program No. 93.774, Medicare—
Supplementary Medical Insurance Program)
Dated: August 20, 2007.
Barry M. Straube,
Chief Medical Officer and Director, Office
of Clinical Standards and Quality, Centers
for Medicare & Medicaid Services.
[FR Doc. E7–16825 Filed 8–23–07; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7005–N]
Medicare Program; Meeting of the
Advisory Panel on Medicare
Education, September 20, 2007
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
yshivers on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: In accordance with the
Federal Advisory Committee Act, 5
U.S.C. Appendix 2, section 10(a) (Pub.
L. 92–463), this notice announces a
meeting of the Advisory Panel on
Medicare Education (the Panel) on
September 20, 2007. The Panel advises
and makes recommendations to the
Secretary of Health and Human Services
(the Secretary) and the Administrator of
the Centers for Medicare & Medicaid
Services on opportunities to enhance
the effectiveness of consumer education
strategies concerning the Medicare
program. This meeting is open to the
public.
VerDate Aug<31>2005
14:35 Aug 23, 2007
Jkt 211001
Meeting Date: September 20,
2007 from 9 a.m. to 3:30 p.m., E.D.T.
Deadline for Meeting Registration,
Presentations, and Written Comments:
September 13, 2007, 12 p.m., E.D.T.
Deadline for Requesting Special
Accommodations: September 5, 2007,
12 p.m., E.D.T.
ADDRESSES: Meeting Location: Hotel
Palomar, 2121 P Street, NW.,
Washington, DC 20037, (202) 448–1800.
Meeting Registration, Presentations,
and Written Comments: Lynne Johnson,
Health Insurance Specialist, Division of
Forum and Conference Development,
Office of External Affairs, Centers for
Medicare & Medicaid Services, 7500
Security Boulevard, Mail stop S1–05–
06, Baltimore, MD 21244–1850 or
contact Ms. Johnson via e-mail at
Lynne.Johnson@cms.hhs.gov.
Meeting Registration: The meeting is
open to the public, but attendance is
limited to the space available. Persons
wishing to attend this meeting must
register by contacting Lynne Johnson at
the address listed in the ADDRESSES
section of this notice or by telephone at
(410) 786–0090, by 12 p.m., E.D.T., on
September 13, 2007.
FOR FURTHER INFORMATION CONTACT:
Lynne Johnson, (410) 786–0090. Please
refer to the CMS Advisory Committees’
Information Line (1–877–449–5659 toll
free)/(410–786–9379 local) or the
Internet (https://www.cms.hhs.gov/
FACA/04_APME.asp) for additional
information and updates on committee
activities. Press inquiries are handled
through the CMS Press Office at (202)
690–6145.
SUPPLEMENTARY INFORMATION: Section
222 of the Public Health Service Act (42
U.S.C. 217a), as amended, grants to the
Secretary the authority to establish an
advisory panel if the Secretary finds the
panel necessary and in the public
interest. The Secretary signed the
charter establishing this Panel on
January 21, 1999 and approved the
renewal of the charter on November 14,
2006. The establishment of the charter
and the renewal of the charter were
announced in the February 17, 1999
Federal Register (64 FR 7899), and the
March 23, 2007 Federal Register (72 FR
13796), respectively. The Panel advises
and makes recommendations to the
Secretary and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) on opportunities to
enhance the effectiveness of consumer
education strategies concerning the
Medicare program.
The goals of the Panel are as follows:
• To develop and implement a
national Medicare education program
DATES:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
that describes the options for selecting
a health plan under Medicare.
• To enhance the Federal
government’s effectiveness in informing
the Medicare consumer, including the
appropriate use of public-private
partnerships.
• To expand outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of a national Medicare
education program.
• To assemble an information base of
best practices for helping consumers
evaluate health plan options and build
a community infrastructure for
information, counseling, and assistance.
The current members of the Panel are:
Anita B. Boles, Independent Consultant,
Health Communications; Gwendolyn T.
Bronson, SHINE/SHIP Counselor,
Massachusetts SHINE Program; Dr.
Yanira Cruz, President and Chief
Executive Officer, National Hispanic
Council on Aging; Clayton Fong,
President and Chief Executive Officer,
National Asian Pacific Center on Aging;
Nan Kirsten-Forte, Executive Vice
President, Consumer Services, WebMD;
Dr. Jessie C. Gruman, President and
Chief Executive Officer, Center for the
Advancement of Health; Betty L.
Kennard, Vice President, Government
Programs and Compliance, Health First
Health Plans; Dr. David Lansky,
Director, Health Program, Markle
Foundation; Dr. Daniel Lyons, Senior
Vice President, Government Programs,
Independence Blue Cross; Dr. Frank B.
McArdle, Manager, Hewitt Research
Office, Hewitt Associates; Traci
McClellan, J.D., Executive Director,
National Indian Council on Aging; Dr.
Keith Mueller, Professor and Section
Head, Health Services Research and
Rural Health Policy, University of
Nebraska; Lee Partridge, Senior Health
Policy Advisor, National Partnership for
Women and Families; Myisha M.
Patterson, National Health Coordinator,
National Association for the
Advancement of Colored People;
Rebecca Snead, Executive Vice
President/Chief Executive Officer,
National Alliance of State Pharmacy
Associations; William A. Steel,
President, The National Grange; Marvin
Tuttle, Jr., CAE, Executive Director and
Chief Executive Officer, Financial
Planning Association; Catherine Valenti,
Chairperson and Chief Executive
Officer, Caring Voice Coalition; and
Grant Wedner, Web Education, Daily
Strength, Inc.
The agenda for the September 20,
2007 meeting will include the following:
• Recap of the previous (April 17,
2007) meeting.
E:\FR\FM\24AUN1.SGM
24AUN1
]]>Agencies
[Federal Register Volume 72, Number 164 (Friday, August 24, 2007)]
[Notices]
[Pages 48652-48654]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-16825]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3184-N]
Medicare Program; Meeting of the Medicare Evidence Development
and Coverage Advisory Committee (MedCAC)--October 22, 2007
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting of the Medicare
Evidence Development & Coverage Advisory Committee (MedCAC)
[[Page 48653]]
(``Committee'') entitled CMS Evidentiary Priorities for Medicare. The
Committee generally provides advice and recommendations about whether
scientific evidence is adequate to determine if certain medical items
and services are reasonable and necessary under the Medicare statute.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. App. 2, section 10(a)).
DATES: The public meeting will be held on Monday, October 22, 2007 from
7:30 a.m. until 4:30 p.m., d.s.t.
Deadline for Presentations and Written Comments: Send written
comments and presentations to the address specified in the ADDRESSES
section by 5 p.m., d.s.t. on September 17, 2007.
Deadline for Meeting Registration: For security reasons,
individuals wishing to attend this meeting must register by 5 p.m.
d.s.t. on October 15, 2007.
Deadline for Submitting Request for Special Accommodations: Persons
attending the meeting who are hearing or visually impaired, or have a
condition that requires special assistance or accommodations, are asked
to notify the Executive Secretary as specified in the FOR FURTHER
INFORMATION CONTACT section of this notice.
ADDRESSES: Meeting Location: The meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services, 7500
Security Blvd., Baltimore, MD 21244.
Registration: Register by contacting Maria Ellis 410-786-0309, or
Maria.Ellis@cms.hhs.gov; Centers for Medicare & Medicaid Services,
OCSQ-Coverage and Analysis Group,C1-09-06, 7500 Security Blvd.,
Baltimore, MD 21244.
Presentation and Comment Submission: Submit presentations and
comments to Michelle Atkinson, at MedCACpresentations@cms.hhs.gov.
Web Site: You may access up-to-date information on this meeting at
https://www.cms.hhs.gov/FACA/02_aspTopOfPage.
Submission of Presentations and Comments: Interested persons may
present data, information, or views orally or in writing on issues
pending before the Committee. Please submit written comments and
presentations to the Executive Secretary at the address specified in
the ADDRESSES section of this notice. Presentations once submitted are
final. No further changes to the presentation will be accepted after
submission.
FOR FURTHER INFORMATION CONTACT: Michelle Atkinson, Executive Secretary
for MedCAC, Centers for Medicare & Medicaid Services, OCSQ-Coverage and
Analysis Group, C1-09-06, 7500 Security Blvd., Baltimore, MD 21244.
410-786-2881; Michelle.Atkinson@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Meeting Topic
On December 14, 1998, we published a notice in the Federal Register
(63 FR 68780) to describe the Medicare Coverage Advisory Committee
(MCAC), which provides advice and recommendations to CMS about clinical
issues. The MCAC was subsequently rechartered as the Medicare Evidence
Development and Coverage Advisory Committee (MedCAC).
This notice announces the October 22, 2007 public meeting of the
Committee. This meeting is to assist CMS in developing priorities for
evidence development for issues of major importance to the Medicare
program and the Medicare population to provide a framework for the
scientific community advancement of research projects that concern
Medicare beneficiaries. Certain disease processes account for a large
percentage of services provided to our beneficiaries and specific
treatments and healthcare delivery processes have a great impact on
beneficiary outcomes. The end product of the MedCAC is a priority list
of research topics with the most potential impact on Medicare and
Medicare beneficiaries to contribute to the body of medical evidence
specific to the Medicare populations. Background information about this
topic, including panel materials, is available at https://www.cms.gov/
coverage.
II. Meeting Procedures
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 30 minutes. The
Committee may limit the number and duration of oral presentations to
the time available. If you wish to make formal presentations, you must
do the following:
Notify the Executive Secretary as specified in FOR FURTHER
INFORMATION CONTACT section of the notice.
Submit the following to the address specified in the
ADDRESSES section of this notice by the date specified in the DATES
section of this notice:
A brief statement of the general nature of the evidence or
arguments you wish to present.
The names and addresses of proposed participants.
A written copy of your presentation. Your presentation
should consider the questions we have posed to the Committee and focus
on the issues specific to the topic. The questions will be available on
the following Web site: https://www.cms.hhs.gov/FACA/02_aspTopOfPage.
We require that you declare at the meeting whether you have any
financial involvement with manufacturers of any items or services being
discussed (or with their competitors).
After the public and CMS presentations, the Committee will
deliberate openly on the topic. Interested persons may observe the
deliberations, but the Committee will not hear further comments during
this time except at the request of the chairperson. The Committee will
also allow a 15 minute unscheduled open public session for any attendee
to address issues specific to the topic. At the conclusion of the day,
the members will vote and the Committee will make its recommendation.
III. Registration Instructions
The Coverage and Analysis Group is coordinating meeting
registration. While there is no registration fee, individuals must
register to attend. Register by contacting Maria Ellis as specified in
the ADDRESSES section of this notice by the date as specified in the
DATES section of this notice. Please provide your name (as it appears
on your government-issued identification), address, organization,
telephone, and fax numbers, and e-mail address.
You will receive a registration confirmation with instructions in
preparation for your arrival at the CMS complex. You will be notified
if the seating capacity has been reached.
This meeting is located on Federal property; therefore, for
security reasons, any individuals wishing to attend this meeting must
register by the date specified in the DATES section of this notice.
IV. Security, Building, and Parking Guidelines
This meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival time, we recommend allowing additional time to clear security.
Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Interior and exterior inspection of vehicles (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and
[[Page 48654]]
instructions will be issued after the vehicle inspection.
Passing through a metal detector and inspection of items
brought into the building. We note that all items brought to CMS,
whether personal or for the purpose of demonstration or to support a
demonstration, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for demonstration or to support a demonstration.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 30 to 45
minutes prior to the convening of the meeting.
All visitors must be escorted in areas other than the lower and
first floor levels in the Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: August 20, 2007.
Barry M. Straube,
Chief Medical Officer and Director, Office of Clinical Standards and
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. E7-16825 Filed 8-23-07; 8:45 am]
BILLING CODE 4120-01-P
